To Evaluate the Safety and Efficacy of Baby Soap in 0-36 Months Babies
Phase 4
- Registration Number
- CTRI/2020/03/023827
- Lead Sponsor
- The Himalaya Drug Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects in the age group of 0 to 36 months (inclusive of both genders).
Subjects in general good health as determined from a recent medical history.
Subjects with dry skin will be enrolled in the study.
Subjects mother/legal representative, preferably mother willing to give a voluntary written informed consent and agree to comply with the study protocol.
Exclusion Criteria
A known history or present allergic condition that may require medical attention.
Chronic illness which may influence the cutaneous assessment.
Subjects not willing to stop the use of other soaps during study period.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the safety and efficacy of Extra Moisturizing Baby Soap in study population.Timepoint: Study duration: This study is planned for 8 days.
- Secondary Outcome Measures
Name Time Method To evaluate the safety and efficacy of Extra Moisturizing Baby Soap in study population.Timepoint: Study duration: This study is planned for 8 days